Sorafenib – Soranib – Sorafenat
Generic Content-, Manufactured By Cipla

Sorafenib , is a drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primary liver cancer (hepatocellular carcinoma).

Available As:200 mg tablets